Bixiye
QP89-20 MHCP Pharmacy Benefit Exclusion for Viltepso®
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 09, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2311 - 2320 ee natiijooyinka 3167
Bixiye
QP86-20 Medical Drug Update for New to Market Tanezumab
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 09, 2020
Bixiye
QP85-20 Commercial Pharmacy Benefit Exclusion for Tecartus™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 09, 2020
Bixiye
QP88-20 Commercial Pharmacy Benefit Exclusion for Viltepso®
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 09, 2020
Bixiye
P50R1-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
P65-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
P70-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 2, 2020
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
P67-20 Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
P69-20 Update Early Intensive Developmental and Behavioral Intervention (EIDBI) Authorization Process
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
P68-20 Radiology Cardiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020